Sanofi licenses contract management software

By Nick Taylor

- Last updated on GMT

Related tags Management Sanofi

Sanofi-Aventis Canada has licensed I-many’s suite of software for managing pharmaceutical contracts, with the IT company also performing installation, maintenance and support.

The software suite will be used by Sanofi to manage its entire contracting process from pre-deal analytics through offer development, negotiation, execution, adjudication, post-deal analysis and renewal.

I-many claims that its ContractSphere suite is the only complete solution for managing a contracts lifecycle and that it can enhance the users business processes and give a competitive advantage.

John Rade, president and CEO of I-many, said: "We are thrilled to see the latest generation of the I-many contract management suite being enthusiastically received by world-class pharmaceutical companies such as Sanofi-Aventis​.

Securing Sanofi-Aventis Canada as a customer for ContractSphere in such a rollercoaster economy demonstrates the strength of I-many’s product offering and proves there is sufficient ROI (return on investment) for businesses to justify investment even in today’s environment if they utilise our contract management solutions​.”

Included in the ContractSphere software suite are five programmes, Contract Analytics, Contract Manager, CARS, Government Pricing and CARS Business Intelligence.

A key component of the suite is I-many Contract Manager, which serves as a repository for all a company’s contracts.

By using a central repository I-many claims companies will improve process and pricing policy compliance and enhance audit trail capability throughout the life-cycle of every contract.

The latest addition to the suite is I-many Contract Analytics, which Sanofi is the first company to license. I-many claims this software allows the user to optimise contract revenue and margins, set discounts correctly and understand the deals impact prior to signing.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more